Search
for
Sort by
Research 661–690 of 1000+
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- COVID-19-induced hair shedding and related risk factors: A Saudi perspective
- Ayurvedic Rasayan formulations having potential for managing post COVID ailments- a narrative review
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Hubungan Antara Telogen Effluvium Dengan Kejadian Paska Infeksi Covid-19 Di Klinik Sukma Periode Januari 2023-Februari 2023
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Adiantum capillus-veneris Linn (Maidenhair fern) extract-based drug as a symptomatic treatment for COVID-19. (clinical candidate)
- Faculty Opinions recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”.
- Enanthem in Patients With COVID-19 and Skin Rash
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Exploiting Unique Features of Microneedles to Modulate Immunity
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- The COVID-19 pandemic and its skin effects
- Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.